摘要
Christopher Toshihiro WIRYA 医师
皮肤科医师
Comparative Analysis of Topical and Oral Minoxidil in Asian Patients with Androgenetic Alopecia: A Case Study of Treatment Response
Objectives: To compare the efficacy of topical and oral minoxidil in treating androgenetic alopecia in Asian patients, utilizing a sample of ten individuals, and to assess the impact of transitioning from oral to topical minoxidil on treatment outcomes.
Introduction: Androgenetic alopecia (AGA), commonly known as male or female pattern baldness, is a prevalent form of hair loss affecting a significant proportion of the global population, including individuals of Asian descent. Among the available treatment options for AGA, minoxidil has emerged as a cornerstone therapeutic agent, demonstrating efficacy in promoting hair regrowth and arresting further hair loss.
Both topical and oral formulations of minoxidil have been extensively utilized in clinical practice, yet limited comparative data exist regarding their relative effectiveness, partic
Materials / method: Participants: Ten Asian AGA patients were divided into groups. Group A received topical minoxidil, Group B received oral minoxidil.
Procedure: Treatment lasted six months, with monthly follow-ups. Hair density, scalp coverage, and subjective feedback were assessed. Group B patients transitioning to topical were monitored for three months.
Analysis: Changes were compared within and between groups statistically. Limitations included small sample size and short follow-up.
Results: Oral minoxidil demonstrated fewer side effects and greater ease of adherence compared to topical formulations. Patients reported minimal adverse effects and found oral administration more convenient, potentially enhancing treatment compliance.
Conclusion: Both oral and topical minoxidil showed efficacy in treating Asian AGA patients. Oral minoxidil had fewer side effects and better adherence. Transition to topical minoxidil led to reduced efficacy. Larger, longer-term studies are needed for definitive conclusions on treatment outcomes.
披露 - Christopher Toshihiro WIRYA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2024年 8月 28日 - Recorded during IMCAS Asia 2024